Please provide a concise study guide on central nervous system infections for medical students.

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CNS Infections Study Guide for Medical Students

Classification and Etiology

CNS infections are categorized by anatomic location and causative organism, with bacterial causes being most prevalent (73% combined), followed by fungal (10%), viral (4%), and parasitic (4%) infections. 1

Major Categories:

  • Meningitis: Inflammation of meninges (bacterial, viral, tuberculous, fungal)
  • Encephalitis: Brain parenchymal inflammation (predominantly viral, especially HSV)
  • Cerebritis/Brain Abscess: Focal brain tissue infection
  • Meningoencephalitis: Combined meningeal and parenchymal involvement 2, 3

Common Pathogens by Type:

  • Bacterial: Tuberculous meningitis (36%), pyogenic bacteria (23%), tuberculoma (14%) 1
  • Viral: HSV, VZV, enteroviruses 4
  • Fungal: Mucormycosis (9%), Cryptococcus (1%) - particularly in immunocompromised 1
  • Parasitic: Neurocysticercosis (3%), toxoplasmosis 1

Clinical Presentation

Cardinal Features (in order of frequency):

  • Fever (80% of cases) 1
  • Headache (67%) 1
  • Altered mental status/encephalopathy 1, 5
  • Neck stiffness (62%) 1
  • Seizures (less common but significant) 1
  • Focal neurologic deficits 6

Presentation Timeline:

  • Acute presentations dominate (83% of cases) 1
  • Most commonly affects middle-aged adults (41-60 years, 43%), followed by young adults (21-40 years, 31%) 1
  • Male predominance (58%) 1

High-Risk Populations:

  • HIV/AIDS patients (31% of CNS infection cases) 1
  • Recent neurosurgery patients 7
  • Patients with CSF shunts, drains, or implantable devices 7
  • Head/spinal trauma 7

Critical Diagnostic Algorithm

Step 1: Immediate Clinical Assessment

If altered consciousness with inability to protect airway → immediate intubation before further workup. 8

Key clinical predictors for CNS infection (use for rapid screening): 6

  • Age <56 years
  • Fever ≥38°C (100.4°F)
  • Glasgow Coma Scale <14
  • Focal neurologic deficit
  • Seizure
  • AIDS/HIV status

Step 2: Distinguish Encephalitis from Encephalopathy

This distinction fundamentally changes management: 8

Encephalitis indicators:

  • Fever + altered mental status + focal findings
  • Requires immediate empiric acyclovir
  • Requires urgent LP (if no contraindications)

Encephalopathy indicators:

  • Metabolic derangements present
  • No fever or focal findings typically
  • Requires identification of precipitating factors

Step 3: Neuroimaging BEFORE Lumbar Puncture

CT brain scan must be performed before LP in most patients to exclude contraindications. 8

Brain MRI with diffusion-weighted imaging is preferred and should be performed within 24 hours to confirm diagnosis and determine extent of inflammation. 9

Step 4: Obtain Blood Cultures

Draw blood cultures before initiating antimicrobials (positive in 28% of brain infection cases). 9

Consider HIV testing in ALL patients regardless of risk factors. 9

Step 5: Lumbar Puncture and CSF Analysis

Perform LP if no contraindications for culture, PCR, and analysis. 9


CSF Interpretation: The Critical Differentiator

Viral Meningitis Pattern:

  • WBC: 5-1000 cells/μL (lymphocyte predominance, though neutrophils may predominate early) 4
  • Appearance: Clear 4
  • Protein: Mildly elevated (<0.6 g/L) 4
  • Glucose: Normal or slightly low 4
  • CSF/plasma glucose ratio: Normal or slightly low but >0.36 4
  • Opening pressure: Normal or mildly raised 4
  • Lactate: <2 mmol/L (effectively rules out bacterial disease) 4

Bacterial Meningitis Pattern:

  • WBC: >100 cells/μL (typically much higher, neutrophil predominance) 4
  • Appearance: Turbid, cloudy 4
  • Protein: Raised 4
  • Glucose: Very low 4
  • CSF/plasma glucose ratio: Very low 4
  • Opening pressure: Raised 4

Tuberculous Meningitis Pattern:

  • WBC: 5-500 cells/μL (lymphocyte predominance) 4
  • Appearance: Clear or cloudy 4
  • Protein: Markedly raised 4
  • Glucose: Very low 4
  • Opening pressure: Raised 4

Critical CSF Pearls:

  • In 5-10% of viral encephalitis (especially HSV), initial CSF may be completely normal 4
  • If first CSF is normal with high clinical suspicion, repeat LP in 24-48 hours 4
  • CSF red cells elevated in ~50% of HSV encephalitis due to hemorrhagic nature 4
  • PCR for HSV-1/2, VZV, and enteroviruses identifies 90% of viral cases 4

Empiric Treatment: Time-Critical Decisions

For Suspected Encephalitis (Viral):

START IV ACYCLOVIR IMMEDIATELY before diagnostic results return - HSV encephalitis has high mortality without treatment. 8

  • Dosing: Standard IV acyclovir (reduce dose in renal impairment) 9
  • Duration: 14 days if HSV confirmed 8, or 14-21 days per alternative guidelines 9
  • Critical pitfall: NEVER delay acyclovir while awaiting LP or imaging 8, 9

For Community-Acquired Cerebritis (Bacterial):

Empirical treatment must include: 9

  • Third-generation cephalosporin (covers streptococci and gram-negatives)
  • PLUS Metronidazole (covers anaerobes)
  • PLUS Acyclovir (covers possible HSV)

If bacterial meningitis also suspected, follow meningitis-specific guidelines. 9

Duration: IV antimicrobials for 6-8 weeks for bacterial cerebritis 9

For Encephalopathy (Non-Inflammatory):

Identify and correct precipitating factors (resolves 90% of cases). 8

For hepatic encephalopathy specifically:

  • Lactulose: 30-45 mL (20-30 g) PO three to four times daily, titrated to 2-3 soft stools/day 8
  • Rifaximin: 550 mg twice daily (reduces recurrence by 58% when added to lactulose) 8

Supportive Care and ICU Management

Indications for ICU Admission:

  • Falling level of consciousness → urgent ICU assessment for: 9
    • Airway protection
    • Ventilatory support
    • Raised intracranial pressure management
    • Electrolyte correction

Management of Cerebral Edema:

  • Elevate head of bed to 30° 9
  • Osmotic therapy: Mannitol or hypertonic saline for impending herniation 9
  • Corticosteroids: May be indicated for severe perifocal edema 9

Monitoring Requirements:

  • Frequent neurological status checks to detect deterioration 9
  • Renal function monitoring (acyclovir causes crystalluria/obstructive nephropathy after 4+ days) 9
  • Adequate hydration essential with acyclovir 9

Follow-Up and Complications

End-of-Treatment Confirmation:

Repeat LP at end of treatment to confirm CSF negative for causative pathogen by PCR. 9

Repeat brain imaging if clinical deterioration or to monitor treatment response. 9

Neurosurgical Considerations:

If cerebritis progresses to abscess formation, neurosurgical intervention may be necessary. 9

Long-Term Outcomes:

  • Long-term neurologic sequelae occur in ~45% of brain infection patients 9
  • Referral to specialized neurorehabilitation required for many survivors 9
  • Overall mortality: 21% with appropriate treatment 1, but can reach 60% in healthcare-associated infections 7

Common Pitfalls to Avoid

Diagnostic Pitfalls:

  • Never delay antimicrobials while awaiting diagnostic results - treatment should start immediately when CNS infection suspected 9
  • Don't rely on ammonia levels alone for hepatic encephalopathy diagnosis or monitoring 8
  • Don't assume normal initial CSF rules out viral encephalitis - repeat in 24-48 hours if suspicion high 4
  • Empirical antimicrobials without diagnostic workup can halt the diagnostic pathway 9

Treatment Pitfalls:

  • Never delay acyclovir for imaging or LP in suspected encephalitis 8, 9
  • Don't forget to adjust acyclovir dose in renal impairment 9
  • Monitor for acyclovir nephrotoxicity with adequate hydration 9

Prognostic Considerations:

  • After first episode of hepatic encephalopathy: Start secondary prophylaxis with lactulose 8
  • Consider liver transplant evaluation after first episode or if recurrent/intractable 8

Related Questions

What are high-yield Bloom's taxonomy level 3, 4, 5 questions on Central Nervous System (CNS) infections relevant to Master of Chirurgie (MCh) Neurosurgery exams like Indian Nationals (INI) Super Speciality (SS)?
What are the common causative agents, classical presentations, and histological findings of central nervous system (CNS) infections, including bacterial, viral, fungal, and parasitic infections?
What is the recommended initial assessment, diagnostic workup, and empiric treatment for a child with suspected central nervous system infection, including infants and older children?
What are the key components and management strategies for a CNS (Central Nervous System) case sheet?
What are the treatment options for central nervous system (CNS) infections caused by Streptococcus agalactiae, Candida, or enterovirus in patients, including neonates and immunocompromised individuals?
What are the signs and symptoms of splenic infarction?
In a 71-year-old woman with a urine culture showing >100,000 CFU mixed gram‑negative rods and budding yeast but no dysuria, frequency, urgency, flank pain, or fever, should she be treated for asymptomatic bacteriuria?
What is the appropriate dose and duration of ciprofloxacin for a male patient with a urinary tract infection, a chronic indwelling catheter, and a glomerular filtration rate of 52 mL/min?
What is the standard dosing schedule, administration details, and monitoring recommendations for the FOLFIRINOX (folinic acid, fluorouracil, irinotecan, oxaliplatin) chemotherapy regimen used in pancreatic adenocarcinoma?
What are the etiologies of pulmonitis in children?
Can a negative hepatitis B surface antigen (HBsAg) test in a patient with improving jaundice indicate that he was never infected with hepatitis B?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.